Mine and Rupa (2003) [1236] identified residues 38-49, 95-102, 191-200, 243-248 and 251-260 as IgE-binding regions using a series of dodecapeptides offset by two amino acids from the previous peptide. The sera were from 18 patients with positive double-blind, placebo-controlled food challenges to egg white.
Elsayed andStavseng (1994) [1237] used enzyme-digested fragments of ovalbumin and synthetic peptides to identify residues 1-19, 34-46 and 47-55 as allergenic. Honma et al (1996) [1238] identified IgE binding to residues 357-366 using a similar approach.
Allergen stability: Process, chemical, enzymatic
de Groot J and de Jongh (2003) [1239] show by DSC that thermal denaturation of native ovalbumin occurs at about 75°C in 20 mM phosphate buffer (pH 7.0) but at approximately 85°C if the more stable S-ova form (see below) is used.
Tagaki et al. (2003) [1244] reported that ovalbumin was relatively stable to both simulatated gastric and intestinal fluid and that preheating increased the stability to proteolysis.
Mine and Zhang (2002) [1245] found that ovalbumin retained its IgE binding capacity after denaturation by reduction and carboxymethylation, heat or urea. This suggests that IgE bound to linear epitopes which are thermostable.
Nature of main cross-reacting proteins:
Not known.
Allergen properties & biological function:
Ovalbumin functions as a storage protein in egg and is approximately 55% (w/w) of the egg white protein (Burley & Vadehra, 1989) [1258]. Although ovalbumin is a member of the serpin family, native ovalbumin, N-ova, is not a protease inhibitor. The inhibitory serpin central loop forms an alpha-helix (Stein et al. 1991) [1226] and proteolysis does not lead to insertion of this region into the beta-sheet and the dramatic conformation change seen in active serpins (Wright et al. 1990) [1225].
Native ovalbumin has a single solvent accessible disulphide bridge and four reduced cysteines which are buried. It is slowly converted in eggs into two more stable forms, I-ova and S-ova (Smith and Back, 1965) [1228]. I-ova is a reversible inhibitor of cathepsin G, chymotrypsin, bovine pancreatic trypsin, porcine pancreatic elastase and αlpha-lytic proteinase (Mellet et al, 1996) [1227]. S-ovalbumin has a similar fold to native ovalbumin (Yamasaki et al. 2003) [1655]. Conversion of 3 serine residues from L- to D-isomers probably accounts for the stabilization (Takahashi et al. 2005) [1656].
Ovalbumin is also N-glycosylated on asparagine 293 (Glabe et al, 1980 [1233]; Rago et al, 1992 [1235]), N-terminally acetylated (Narita and Ishii, 1962 [1234]) and phosphorylated at serine 68 and/or 344 (Nisbet et al, 1981 [1232]) with an average 1.73 phosphates per molecule (Ekman and Jäger, 1993 [1231]) and thus a dominant diphosphorylated form.
Allergen purification:
de Groot J and de Jongh (2003) [1239] describe a method derived from Vachier et al. (1995) [1240] and Takahashi et al. (1996) [1241]. Egg white for purification of ovalbumin was separated from egg yolk by hand using nine hen eggs less than 6-8 h old. To the total egg white fraction (about 300 ml), 600 ml of a 50 mM Tris-HCl buffer, pH 7.5, containing 10 mM ß-mercaptoethanol was added. This solution was stirred for 6 h at 4°C. Subsequently, the solution was centrifuged for 30 min at 18 000 g and 4°C. The pellet was discarded and 1800 ml of 50 mM Tris-HCl, pH 7.5, were added carefully to the supernatant. To the diluted supernatant, 500 g of DEAE Sepharose Cl-6B (Pharmacia) were added, followed by overnight incubation at 4°C with gentle stirring. Next, the DEAE was collected on a glass filter, followed by extensive washing with 2.5 l of demineralized water and 2.5 l of 0.1 M NaCl successively. The protein was eluted stepwise with six subsequent volumes of 300 ml containing 0.15 M NaCl. The protein solution was concentrated using a Millipore ultrafiltration unit with a 30 kDa molecular mass cut-off membrane. The concentrated solution was dialyzed extensively against demineralized water at 4°C and then freeze-dried. The freeze-dried ovalbumin was stored at 40°C until further use. They report a yield of about 1.1 g of ovalbumin per egg and the efficiency of isolation is about 60%. A protein purity of >98% was estimated from densitometric analysis from an SDS-PAGE gel.
Other biochemical information:
Binding of a T-cell epitope of ovalbumin to the histocompatibility complex has been characterised by Fremont et al. (1995) [1229].
Ovalbumin has been used as an allergen in many animal model studies of allergy (Strid et al. (2004) [1246]; Pilegaard & Madsen, 2004 [1247]).
Anti-ovalbumin IgE is constituitively expressed in a strain of mice created by Matsuoka et al. (1999) [1257] and these have been used by Sato et al. (2003) [1256] and Omata et al. (2005) [1255] as animal models of food allergy.
Ovalbumins from the eggs of other birds have very similar sequences (O73860 from turkey has 90% identical residues while P19104 and Q6V115 from Japanese and common quail have 88% and 87% respectively) and thus are likely to show IgE cross-reactivity. There is a related sequence in chicken P01014 with 57% identity which also might show IgE cross-reactivity.
References (27)
Burley, R. W.; Vadehra, D. V.
The albumin: chemistry.
In The Avian Egg. Chemistry and Biology; Burley, R. W., Vadehra, D. V., Eds.; Wiley: New York, 1989; pp 65-128. 1989
PUBMED ID:
unknown
[1258]
de Groot J, de Jongh HH.
The presence of heat-stable conformers of ovalbumin affects properties of thermally formed aggregates.
Protein Eng. 16(12):1035-1040.
2003
PUBMED ID:
14983084
Ekman P, Jager O.
Quantification of subnanomolar amounts of phosphate bound to seryl and threonyl residues in phosphoproteins using alkaline hydrolysis and malachite green.
Anal Biochem. 214(1):138-141. 1993
PUBMED ID:
8250216
Elsayed S, Stavseng L.
Epitope mapping of region 11-70 of ovalbumin (Gal d I) using five synthetic peptides.
Int Arch Allergy Immunol. 104(1):65-71.
1994
PUBMED ID:
7950407
Fremont DH, Stura EA, Matsumura M, Peterson PA, Wilson IA.
Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove.
Proc Natl Acad Sci U S A. 92(7):2479-2483. 1995
PUBMED ID:
7708669
Kelly JF, Locke SJ, Ramaley L, Thibault P.
Development of electrophoretic conditions for the characterization of protein glycoforms by capillary electrophoresis-electrospray mass spectrometry.
J Chromatogr A. 720(1-2):409-427. 1996
PUBMED ID:
8601204
Matsuoka K, Taya C, Kubo S, Toyama-Sorimachi N, Kitamura F, Ra C, Yonekawa H, Karasuyama H.
Establishment of antigen-specific IgE transgenic mice to study pathological and immunobiological roles of IgE in vivo.
Int Immunol. 11(6):987-994. 1999
PUBMED ID:
10360973
Mine Y, Rupa P.
Fine mapping and structural analysis of immunodominant IgE allergenic epitopes in chicken egg ovalbumin.
Protein Eng. 2003 Oct;16(10):747-752.
2003
PUBMED ID:
14600204
Mine Y, Zhang JW.
Comparative studies on antigenicity and allergenicity of native and denatured egg white proteins.
J Agric Food Chem. 50(9):2679-2683.
2002
PUBMED ID:
11958641
Pilegaard K, Madsen C.
An oral Brown Norway rat model for food allergy: comparison of age, sex, dosing volume, and allergen preparation.
Toxicology 196(3):247-257.
2004
PUBMED ID:
15036751
Sato E, Hirahara K, Wada Y, Yoshitomi T, Azuma T, Matsuoka K, Kubo S, Taya C, Yonekawa H, Karasuyama H, Shiraishi A.
Chronic inflammation of the skin can be induced in IgE transgenic mice by means of a single challenge of multivalent antigen.
J Allergy Clin Immunol. 111(1):143-148.
2003
PUBMED ID:
12532110
Smith MB, Back JF.
Studies on ovalbumin: II. The formation and properties of S-ovalbumin a more stable form.
Aust. J. Biol. Sci., 18, 365–377. 1965
PUBMED ID:
unknown
[1228]
Stein PE, Leslie AG, Finch JT, Carrell RW.
Crystal structure of uncleaved ovalbumin at 1.95 A resolution.
J Mol Biol. 221(3):941-959.
1991
PUBMED ID:
1942038
Strid J, Thomson M, Hourihane J, Kimber I, Strobel S.
A novel model of sensitization and oral tolerance to peanut protein.
Immunology 113(3):293-303. 2004
PUBMED ID:
15500615
Takagi K, Teshima R, Okunuki H, Sawada J.
Comparative study of in vitro digestibility of food proteins and effect of preheating on the digestion.
Biol Pharm Bull. 26(7):969-973. 2003
PUBMED ID:
12843620
Takahashi N, Onda M, Hayashi K, Yamasaki M, Mita T, Hirose M.
Thermostability of refolded ovalbumin and S-ovalbumin.
Biosci Biotechnol Biochem. 69(5):922-931.
2005
PUBMED ID:
15914911
Takahashi N, Tatsumi E, Orita T, Hirose M.
Role of the intrachain disulfide bond of ovalbumin during conversion into S-ovalbumin.
Biosci Biotechnol Biochem. 1996 Sep;60(9):1464-8.
1996
PUBMED ID:
8987595
Vachier MC, Piot M, Awade AC.
Isolation of hen egg white lysozyme, ovotransferrin and ovalbumin, using a quaternary ammonium bound to a highly crosslinked agarose matrix.
J Chromatogr B Biomed Appl. 664(1):201-210.
1995
PUBMED ID:
7757226
Wright HT, Qian HX, Huber R.
Crystal structure of plakalbumin, a proteolytically nicked form of ovalbumin. Its relationship to the structure of cleaved alpha-1-proteinase inhibitor.
J. Mol. Biol. 213(3), 513–528. 1990
PUBMED ID:
2352279
Yamasaki M, Takahashi N, Hirose M.
Crystal structure of S-ovalbumin as a non-loop-inserted thermostabilized serpin form.
J Biol Chem. 278(37):35524-35530. 2003
PUBMED ID:
12840013